Biowave Technology

BioWave is a pain blocking technology. It relies on what’s called the “Frequency Conduction Block Theory”, this patented technology administers high-frequency electrical signals passing through the skin into deep tissue. These signals travel to the surface of nerves surrounding the pain site. It is explained that BioWave is a better approach than electrical stimulation units (TENS) used so frequently in practice. 

BioWave’s patented, proven, effective neuro-stimulation has and still is changing lives every day. It delivers therapeutic electrical signals into deep tissue. Patients immediately feel the difference and return often requesting the treatment due to its relief of pain.

What are differences between TENS and Biowave?

BioWave utilizes a proprietary signal technology that delivers high-frequency alternating current signals through skin into deep tissue and creates new set of signals, one of which is in the form of a low-frequency electrical field. Percutaneous electrodes can provide even longer lasting pain relief. 

Biowave Percutaneous Neurostimulation (PENS) procedure

Usually the patient is prescribed diagnostic implantation of neuro-stimulation device through placement of Biowave Percutaneous Neurostimulation (PENS) needle array electrodes. As a result of incomplete healing, slow improvement and pain plateauing, pre and post-surgery and trsuma induced soft tissue injuries such as motor vehicle accident and work injuries. 

Biowave Percutaneous Neurostimulation (PENS). Biowave Percutaneous Neurostimulation (PENS) delivers therapeutic signals through an electrode array 1014 micro-needles to block pain signals at the surface of the nerve.

Biowave Percutaneous Neurostimulation (PENS) provides a direct conductive pathway through the skin into deep tissue, creating an active electrical field in a 3.5” diameter beneath each percutaneous electrode which yields a much more effective treatment than TENS. 

Applying Biowave Percutaneous Neurostimulation (PENS) to an area pre or post-surgical helps activate deep C-fibers therefore blocking pain also utilizing this treatment concurrent with manual therapy will reduce scar tissue, maintain or increase range of motion. 

Biowave Percutaneous Neurostimulation (PENS) is recommended/medically necessary to provide the patient and effective pain management option in order to improve functional capacity and well-being, as well as reduce the need for oral pain medications.

The overall goals are; reduce injury time, promote faster healing as well as reduce other more invasive treatments.

The patient is administered Percutaneous Neurostimulation (PENS) device through placement of needle array electrodes through the skin. the patient is advised of the potential risks and benefits including but not limited to pain at the electrode sites, skin irritation, local
reaction to electrode adhesive or stainless steel allergy.

Nerve stimulation is provided by signals which uses electrodes containing a group of individual needles or an array of needles to pass through the outer layers of skin piercing the barrier which provides a direct conductive pathway through skin into deeper tissues. 

Neuromodulation Therapy

Utilizing neuromodulation therapy with needle array electrodes is medically necessary and clinically indicated for bypassing the impedance of the skin for more pain relief and pain control. 

The patient is taken to the exam room and the two areas of maximal tenderness are identified. The areas are marked, the area is cleaned with an alcohol swab and then allowed to air dry.

The needle array is removed from the sealed packaging and placed over the marked areas. Both thumbs are used to apply perpendicular pressure at greater than 20lbs of pressure per square inch over the needle array penetrating each through the dermal layer into the subcutaneous layer. The neurostimulator needle including nerve fiber membrane like C-fibers (pain fibers).

A-Delta fiber (sensory fiber) and muscle tissue, that lie within a 3inch diameter hemisphere beneath each Needle Array, act like nonlinear devices and cause a mathematical multiplication of the two high frequency waveforms. The result is the that a new spectrum of signals from inside the body, one of which is allow frequency 122 Hz alternating current electrical field in approximately a 3inch diameter hemisphere (115.8 cm3) beneath each percutaneous electrode that interrupts the transmission of pain impulses by preventing action potential propagation along C-fibers and by inducing hypoesthesia (numbness0 in A-delta fibers. 

This will allow more specific delivery of stimulation to the patient’s nerves causing the pain and provide pain control by blocking pain signal pathways to the brain. 

The patient is positioned and instructed on the use of the Biowave Percutaneous Neurostimulation (PENS) device so that the intensity could be controlled through the session. the device is activated to deliver an electrical signal through the skin into deep tissue at the pain site.

The treatment lasted 30 minutes under medical supervision. The patient is involved by communicating the toleration to the increase in intensity.